New treatment hope for amyotrophic lateral sclerosis
2015-06-10
(Press-News.org) A previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been discovered by scientists at the CHUM Research Centre and the University of Montreal. The finding paves the way to a whole new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's and Huntington's diseases.
The study, published today in Nature Communications, shows that the immune system in the animal model C. elegans, a tiny 1 mm-long roundworm, plays a critical role in the development of ALS. 'An imbalance of the immune system can contribute to the destruction of motor neurons and trigger the disease,' said Alex Parker, CRCHUM researcher and associate professor in the Department of Neuroscience at the University of Montreal.
Amyotrophic lateral sclerosis is a neuromuscular disease that attacks neurons and the spinal cord. Those affected gradually become paralyzed and typically die less than five years after the onset of symptoms. No effective remedy currently exists for this devastating affliction. Riluzole, the only approved medication only extends the patient's life by a few months.
More than a dozen genes are related to ALS. If a mutation occurs in one of them, the person develops the disease. Scientists introduced a mutated human gene (TDP-43 or FUS) into C. elegans, a nematode worm widely used for genetic experiments. The worms became paralyzed within about 10 days. The challenge was to find a way of saving them from certain death. 'We had the idea of modifying another gene -- tir-1 -- known for its role in the immune system,' said Julie Veriepe, lead investigator and doctoral student under the supervision of Alex Parker. Results were remarkable. 'Worms with an immune deficit resulting from the tir-1 gene's mutation were in better health and suffered far less paralysis,' she added.
This study highlights a never previously suspected mechanism: even if the C. elegans worm has a very rudimentary immune system, that system triggers a misguided attack against the worm's own neurons. 'The worm thinks it has a viral or bacterial infection and launches an immune response. But the reaction is toxic and destroys the animal's motor neurons,' Alex Parker explained.
Is the same scenario at work with people? Most likely. The human equivalent of the tir-1 gene --
SARM1 -- has proved crucial to the nervous system's integrity. Researchers think the signalling pathway is identical for all genes associated with ALS. This makes the TIR-1 protein (or SARM1 in humans) an excellent therapeutic target for development of a medication. SARM1 is particularly important because it is part of the well-known kinase activation process, which can be blocked by existing drugs.
Alex Parker's team is already actively testing drugs that have been previously approved by the US Food and Drug Administration for treatment of such disorders as rheumatoid arthritis, to see if they work with ALS. Obstacles still remain, however, before finding a remedy for curing or slowing the progression of amyotrophic lateral sclerosis. 'In our studies with worms, we know the animal is sick because we caused the disease. This allows us to administer treatment very early in the worm's life. But ALS is a disease of aging, which usually appears in humans around the age of 55. We do not know if a potential medication will prove effective if it is only given after appearance of symptoms. But we have clearly demonstrated that blocking this key protein curbs the disease's progress in this worm,' Alex Parker concluded.
INFORMATION:
About the study
The study 'Neurodegeneration in C. elegans models of ALS requires TIR-1 / Sarm1 immune activation pathways in neurons' was published in Nature Communications. All authors are affiliated with the CHUM Research Centre and the University of Montreal: Julie Veriepe, Lucresse Fossouo and J. Alex Parker. This research was financially supported by an ALS Canada-Brain Canada Discovery Grant, and the Canadian Institutes of Health Research (CIHR). For more information, see the study online: http://www.nature.com/naturecommunications
ELSE PRESS RELEASES FROM THIS DATE:
2015-06-10
New York, June 10 -- A new paper in the British Medical Journal by Jan Blustein, M.D., Ph.D., of New York University's Wagner School and a professor of Medicine and Population Health at NYU School of Medicine and Jianmeng Liu, M.D., Ph.D., of Peking University examines the evidence as to whether newborns delivered by Cesarean section are more likely to develop chronic diseases later in life. While the jury is still out and research is ongoing, recent studies underscore the need for health care providers to discuss with expectant parents the risk of babies born through cesarean ...
2015-06-10
Companies are spending increasing amounts on cybersecurity tools, but aren't convinced their data is truly secure and many chief information security officers believe that attackers are gaining on their defenses, according to a new RAND Corporation study.
Charting the future of cybersecurity is difficult because so much is shrouded in secrecy, no one is entirely certain of all the methods malicious hackers use to infiltrate systems and businesses do not want to disclose their safety measures, according to the report.
While worldwide spending on cybersecurity is close ...
2015-06-10
CLEVELAND, June 10 -- The use of complementary and alternative medicine (CAM) is increasing for the treatment of menopausal symptoms but often without the guidance of a clinician. That's according to a new study reported online today in Menopause, the journal of the North American Menopause Society (NAMS). As a result, the authors suggest that healthcare providers -- in particular family medicine practitioners -- need to be more aware of the various CAM therapies and take a more active role in guiding patients through their options to more safely and effectively coordinate ...
2015-06-10
Almost one in every 150 babies born in the UK is stillborn or dies soon after birth. A research team led from the University of Leicester has identified large differences across the UK in the numbers and rates of babies who die, even after taking account of known factors that influence the rate of death such as poverty, mother's age and ethnicity.
A new report by MBRRACE-UK*, a team of academics, clinicians and charity representatives (commissioned by the Healthcare Quality Improvement Partnership** as part of the Maternal, Newborn and Infant Clinical Outcome Review Programme), ...
2015-06-10
Brood parasites are reproductive cheats that evolve ways of duping other birds into raising their young. Examples such as mimicry of host eggs, chicks and fledglings by brood parasitic eggs, chicks and fledglings are amongst the most iconic examples of animal deception in nature.
New research shows that adult brood parasitic female cuckoo finches have evolved plumage colours and patterns to mimic a harmless and abundant species, such as southern red bishops, to deceive possible host birds and reduce the risk of being attacked when approaching host nests to lay their eggs. ...
2015-06-10
A young woman has become the first in the world to give birth to a healthy child after doctors restored her fertility by transplanting ovarian tissue that had been removed and frozen while she was a child.
A report of the case is published today in Human Reproduction [1], one of the world's leading reproductive medicine journals. While there have been reports of successful pregnancies after ovarian transplantation using tissue that had been removed from patients when they were adults, there have been none using tissue taken from girls before puberty and the ability of ...
2015-06-10
Scientists at the University of Liverpool have shown that the most complete giant sauropod dinosaur, Dreadnoughtus, discovered by palaeontologists in South America in 2014, was not as large as previously thought.
Found in Patagonia, the huge fossil had almost all of the major bones intact, allowing scientists to confidently estimate its overall size - measuring in at 26 metres long.
Preserved in rock, it is thought that the animal was close to maturity but not fully grown when it died, and may have grown to be even larger. The long-necked, plant-eating dinosaur was ...
2015-06-10
Having a hierarchical social structure with just a few well-connected leaders enables pigeon flocks to navigate more accurately on the wing, new research shows.
Hierarchical organisation also enables flocks to cope better with navigation errors made by individual birds.
Researchers from Oxford University and the Zoological Society of London created 'virtual flocks' of homing pigeons to test how different social networks affect the navigation performance of these groups. The team's simulations looked at everything from no networks (all connections between individuals ...
2015-06-10
A single dose of the bivalent human papillomavirus (HPV) vaccine (Cervarix®, GlaxoSmithKline group of companies) may offer a similar level of protection against HPV-16/18 infections, which cause about 70% of cervical cancers, as the current two- and three-dose schedules, according to new research combining data from two large phase 3 trials published in The Lancet Oncology.
"Our findings question the number of HPV vaccine doses truly needed to protect the majority of women against cervical cancer, and suggest that a one-dose schedule should be further evaluated. ...
2015-06-09
NEW YORK, June 9 -- The World Health Organization released its 2015 updated essential medicines list and for the first time included the progesterone contraceptive vaginal ring (CVR), a contraceptive safe and effective for lactating women in the postpartum period.
The progesterone CVR, developed by the Population Council, is an intravaginal ring that provides women who breastfeed at least four times a day with a contraceptive option as early as four weeks after giving birth. It can be used for up to a year for improved birth spacing.
'More than 220 million women in ...
LAST 30 PRESS RELEASES:
[Press-News.org] New treatment hope for amyotrophic lateral sclerosis
